Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis

Fig. 3

In vitro cumulative release and toxicity of Dex preparations. Cumulative release of Dex from Lip/Dex, Exo/Dex and FPC-Exo/Dex at PBS of pH 7.4 a or pH 6.0 b. Results were shown as mean ± SD (n = 3). The effect of Dex, Lip/Dex, Exo/Dex and FPC-Exo/Dex for HUVEC c and RAW264.7 cells viability d. Data represent mean ± SD (n = 5)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us